Maged Shenouda Relmada Therapeutics, Inc. (RLMD) insider trading activity

RLMD Quotes by TradingView

Maged Shenouda is Chief Financial Officer of RELMADA THERAPEUTICS, INC.. Currently has a direct ownership of 288,335 shares of RLMD, which is worth approximately $204,717. The most recent transaction as insider was on Jan 27, 2021, when has been sold 3,000 shares (Common Stock) at a price of $3.24 per share, resulting in proceeds of $9,720. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 288K
226.41% 3M change
726.1% 12M change
Total Value Held $204,717

Maged Shenouda Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jan 27 2021
BUY
Exercise of conversion of derivative security
$9,720 $3.24 p/Share
3,000 Added 36.46%
5,228 Common Stock
Jan 26 2021
SELL
Open market or private sale
$21,342 $35.16 p/Share
607 Reduced 21.41%
2,228 Common Stock
Jan 25 2021
SELL
Open market or private sale
$45,146 $35.27 p/Share
1,280 Reduced 31.11%
2,835 Common Stock
Jan 22 2021
SELL
Open market or private sale
$75,603 $35.78 p/Share
2,113 Reduced 33.93%
4,115 Common Stock
Jan 22 2021
BUY
Exercise of conversion of derivative security
$1,296,000 $324.0 p/Share
4,000 Added 39.11%
6,228 Common Stock
MS

Maged Shenouda

Chief Financial Officer
New York, NY

Track Institutional and Insider Activities on RLMD

Follow RELMADA THERAPEUTICS, INC. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells RLMD shares.

Notify only if

Insider Trading

Get notified when an Relmada Therapeutics, Inc. insider buys or sells RLMD shares.

Notify only if

News

Receive news related to RELMADA THERAPEUTICS, INC.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on RLMD